{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:54:23Z","timestamp":1773150863983,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCI P30 CA016672"],"award-info":[{"award-number":["NCI P30 CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 CA124787"],"award-info":[{"award-number":["P01 CA124787"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.bbmt.2015.07.036","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T22:31:15Z","timestamp":1438900275000},"page":"226-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Nina","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loretta A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tito R.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin Shelley","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Reuben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qaiser","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffar H.","family":"Qazilbash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles S.","family":"Cleeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio A.","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2015.07.036_bib1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.bmt.1705664","article-title":"Symptom burden in patients undergoing autologous stem-cell transplantation","volume":"39","author":"Anderson","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.036_bib2","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/cncr.23299","article-title":"Symptom burden after autologous stem cell transplantation for multiple myeloma","volume":"112","author":"Campagnaro","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2015.07.036_bib3","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/1078-0432.CCR-13-2442","article-title":"Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation","volume":"20","author":"Wang","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2015.07.036_bib4","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/cncr.23820","article-title":"Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation","volume":"113","author":"Wang","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2015.07.036_bib5","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V106.11.1771.1771","article-title":"Risk factors for development of symptoms post autologous transplant for multiple myeloma","volume":"106","author":"Campagnaro","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.07.036_bib6","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood.V88.8.3223.bloodjournal8883223","article-title":"CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies","volume":"88","author":"Mavroudis","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.07.036_bib7","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood.V86.10.3961.bloodjournal86103961","article-title":"An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy","volume":"86","author":"Weaver","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.07.036_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bmt.1704826","article-title":"Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis","volume":"35","author":"Oran","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.036_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbmt.2007.12.276","article-title":"Larger stem cell dose is associated with decreased symptom severity after autologous stem cell transplantation for multiple myeloma","volume":"14","author":"Williams","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.036_bib10","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V","article-title":"Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory","volume":"89","author":"Cleeland","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2015.07.036_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-8722-6-13","article-title":"Validation of the M. D. Anderson Symptom Inventory multiple myeloma module","volume":"6","author":"Jones","year":"2013","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.bbmt.2015.07.036_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0885-3924(02)00502-X","article-title":"Physical function in patients with cancer: psychometric characteristics and clinical usefulness of a physical performance test battery","volume":"24","author":"Simmonds","year":"2002","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.bbmt.2015.07.036_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01066064","article-title":"A\u00a0comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation","volume":"6","author":"Yeh","year":"1978","journal-title":"J\u00a0Pharmacokinet Biopharm"},{"key":"10.1016\/j.bbmt.2015.07.036_bib14","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.bbmt.2013.08.002","article-title":"Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma","volume":"19","author":"Costa","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.036_bib15","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.bbmt.2015.05.013","article-title":"Cost-effectiveness of autologous hematopoietic stem cell transplantation for elderly patients with multiple myeloma using the Surveillance, Epidemiology, and End Results-Medicare Database","volume":"21","author":"Shah","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.036_bib16","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bbmt.2014.07.013","article-title":"Older patients with myeloma derive similar benefit from autologous transplantation","volume":"20","author":"Sharma","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.036_bib17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.bbmt.2015.03.025","article-title":"Outcome of patients with immunoglobulin light-chain amyloidosis with lung, liver, gastrointestinal, neurologic, and soft tissue involvement after autologous hematopoietic stem cell transplantation","volume":"21","author":"Afrough","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.036_bib18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.bmt.1705384","article-title":"A\u00a0prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation","volume":"37","author":"Lilleby","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.07.036_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clml.2014.02.001","article-title":"The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantation","volume":"14","author":"Fleming","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.bbmt.2015.07.036_bib20","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood-2009-04-205013","article-title":"Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide, lenalidomide-, or bortezomib-containing regimens","volume":"114","author":"Kumar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.07.036_bib21","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1200\/JCO.2000.18.6.1360","article-title":"Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy","volume":"18","author":"Siena","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.07.036_bib22","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1182\/blood.V99.12.4276","article-title":"Autologous stem cell transplantation for primary systemic amyloidosis","volume":"99","author":"Comenzo","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.07.036_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bjh.12266","article-title":"A\u00a0phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma","volume":"161","author":"Voorhees","year":"2013","journal-title":"Br J Haematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115005169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115005169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:52:55Z","timestamp":1761058375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879115005169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1083879115005169"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.07.036","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}